Clinical significance of lndoleamine 2,3-dioxygenase (IDO) and B7-H1 expressions in pancreatic carcinoma patients undergone pancreatoduodenectomy
10.3760/cma.j.issn.1007-8118.2012.07.004
- VernacularTitle:吲哚胺2,3-双加氧酶和B7分子同源蛋白1在胰腺癌组织中的表达及其临床意义
- Author:
Liancai WANG
;
Qingyong MA
;
Deyu LI
;
Xiangli CHEN
;
Haibo YU
;
Chunhui GAO
;
Kun GUO
- Publication Type:Journal Article
- Keywords:
Gene expression;
Pancreatic neoplasms;
Pancreaticoduodenectomy;
Prognosis
- From:
Chinese Journal of Hepatobiliary Surgery
2012;18(7):503-507
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo analyze the relationship between expressions of Indoleamine 2,3-dioxygenase (IDO) and B7-H1 with clinico-pathological features and their prognostic significance in pancreatic cancer (PC).Method95 patients who underwent radical pancreaticoduodenectomy for PC were studied.The IDO and B7-H1 expressions in tissue specimens were determined by immunohistochemistry.ResultsIDO and B7-H1 expressions were higher in pancreatic carcinoma tissues than in normal pancreatic tissues (P<0.05).IDO and B7-H1 expressions positively and significantly correlated with pathological grades and tumour-node-metastasis (TNM) stages (P<0.05).They were prognostic of poor cancer-specific survival.After adjusting by the Cox proportional hazards regression models (P<0.05),only a combined IDO/B7-H1 expression served as an independent prognostic marker.ConclusionsIDO and B7-H1 were expressed in PC,and they were important markers for malignant progression of PC.A combined IDO/B7-H1 expression served as an independent prognostic marker for PC.